Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis.

JAMA Neurol

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Published: January 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682942PMC
http://dx.doi.org/10.1001/jamaneurol.2023.4514DOI Listing

Publication Analysis

Top Keywords

potential medicare
4
medicare medicaid
4
medicaid savings
4
savings anti-cd20
4
anti-cd20 therapy
4
therapy multiple
4
multiple sclerosis
4
potential
1
medicaid
1
savings
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!